Stocksigma LogoStocksigma Logo

Sun Pharma Approves Up to ₹10,000 Crore NCD Issuance and Announces Board Resignation

Sun Pharmaceutical Industries' Board approved the issuance of listed, rated, unsecured, redeemable Non-Convertible Debentures (NCDs) on a private placement

Sun Pharma Approves Up to ₹10,000 Crore NCD Issuance and Announces Board Resignation

Sun Pharmaceutical Industries Ltd · Outcome · 13 Oct 2026, 1:26 am

Sun Pharma Approves Up to ₹10,000 Crore NCD Issuance and Announces Board Resignation Sun Pharmaceutical Industries' Board approved the issuance of listed, rated, unsecured, redeemable Non-Convertible Debentures (NCDs) on a private placement basis for an aggregate amount not exceeding INR 10,000 Crore, in one or more tranches. The Board also authorized its Finance Committee to determine tranche-specific terms, issuance, allocation, and allotment. Separately, Non-Executive Independent Director Gautam Doshi resigned with immediate effect on 12th Oct'26, citing personal commitments, consequently stepping down from all Board committees and subsidiary directorships with no other material reasons reported.

Original exchange filing (PDF)

More announcements from Sun Pharmaceutical Industries Ltd

All Sun Pharmaceutical Industries Ltd announcements